Predictive factors for clinical response to allergy immunotherapy in children with asthma and rhinitis

International Archives of Allergy and Immunology

Volumn 164, Issue 3, 2014, Pages 210-217

  Li, Qiaoling ^a   Li, Mengrong ^a   Yue, Wei ^a   Zhou, Jinsi ^a   Li, Ruxia ^a   Lin, Jian ^a   Li, Yingchun ^a  

^a THE SECOND AFFILIATED HOSPITAL AND YUYING CHILDREN S HOSPITAL OF WENZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Allergy immunotherapy; Serum immunoglobulin E; Tobacco smoke exposure

Indexed keywords

HOUSE DUST ALLERGEN; IMMUNOGLOBULIN E; TOBACCO SMOKE; ALLERGEN; PASSIVE SMOKING; SMOKE;

ALLERGIC ASTHMA; ALLERGIC RHINITIS; ALLERGY IMMUNOTHERAPY; AREA UNDER THE CURVE; ARTICLE; ATOPY; CHILD; CHILDHOOD DISEASE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DERMATOPHAGOIDES; EOSINOPHIL COUNT; FAMILY HISTORY; FEMALE; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRICK TEST; RETROSPECTIVE STUDY; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY; SKIN TEST; SUBCUTANEOUS IMMUNOTHERAPY; TREATMENT RESPONSE; ADOLESCENT; ANIMAL; ASTHMA; BLOOD; DESENSITIZATION; EOSINOPHIL; IMMUNOLOGY; LEUKOCYTE COUNT; PASSIVE SMOKING; PRESCHOOL CHILD; PYROGLYPHIDAE; RECEIVER OPERATING CHARACTERISTIC; RHINITIS, ALLERGIC, PERENNIAL; SMOKE; TREATMENT OUTCOME;

ADOLESCENT; ALLERGENS; ANIMALS; ASTHMA; CHILD; CHILD, PRESCHOOL; DESENSITIZATION, IMMUNOLOGIC; EOSINOPHILS; FEMALE; HUMANS; IMMUNOGLOBULIN E; LEUKOCYTE COUNT; MALE; PYROGLYPHIDAE; RETROSPECTIVE STUDIES; RHINITIS, ALLERGIC, PERENNIAL; ROC CURVE; SKIN TESTS; SMOKE; TOBACCO SMOKE POLLUTION; TREATMENT OUTCOME;

EID: 84906027380     PISSN: 10182438     EISSN: 14230097     Source Type: Journal    
DOI: 10.1159/000365630     Document Type: Article

References (30)

1. Papadopoulos NG, Arakawa H, Carlsen K-H, et al: International consensus on (icon) pediatric asthma. Allergy 2012; 67: 976-997.
2. Burks AW, Calderon MA, Casale T, Cox L, Demoly P, Jutel M, Nelson H, Akdis CA: Update on allergy immunotherapy: American Academy of Allergy, Asthma and Immunology/ European Academy of Allergy and Clinical Immunology/PRACTALL consensus report. J Allergy Clin Immunol 2013; 131: 1288-1296.
3. Abramson MJ, Puy RM, Weiner JM: Injection allergen immunotherapy for asthma. Cochrane Database Syst Rev 2010; 8:CD001186.
4. Meadows A, Kaambwa B, Novielli N, Huissoon A, Fry-Smith A, Meads C, Barton P, Dretzke J: A systematic review and economic evaluation of subcutaneous and sublingual allergen immunotherapy in adults and children with seasonal allergic rhinitis. Health Technol Assess 2013; 17: 1-322.
5. Yukselen A, Kendirli SG, Yilmaz M, Altintas DU, Karakoc GB: Effect of one-year subcutaneous and sublingual immunotherapy on clinical and laboratory parameters in children with rhinitis and asthma: a randomized, placebo-controlled, double-blind, double-dummy study. Int Arch Allergy Immunol 2012; 157: 288-298.
6. Senti G, von Moos S, Tay F, Graf N, Sonderegger T, Johansen P, Kundig TM: Epicutaneous allergen-specific immunotherapy ameliorates grass pollen-induced rhinoconjunctivitis: a double-blind, placebo-controlled dose escalation study. J Allergy Clin Immunol 2012; 129: 128-135.
7. Senti G, Crameri R, Kuster D, Johansen P, Martinez-Gomez JM, Graf N, Steiner M, Hothorn LA, Gronlund H, Tivig C, Zaleska A, Soyer O, van Hage M, Akdis CA, Akdis M, Rose H, Kundig TM: Intralymphatic immunotherapy for cat allergy induces tolerance after only 3 injections. J Allergy Clin Immunol 2012; 129: 1290-1296.
8. Nouri HR, Sankian M, Afsharzadeh D, Varasteh A: Immunotherapy with a recombinant hybrid molecule alleviates allergic responses more efficiently than an allergenic cocktail or pollen extract in a model of Chenopodium album allergy. Int Arch Allergy Immunol 2013; 161: 325-332.
9. Global Initiative for Asthma: Global Strategy for Asthma Management and Prevention: NHLBI/WHO Workshop Report, publication No. 95-3659. Bethesda, National Institute of Health and National Heart, Lung and Blood Institute, 1995.
10. Bousquet J, Van Cauwenberge P, Khaltaev N; ARIA Workshop Group (World Health Organization): Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001; 108(suppl 5):S147-S334.
11. Alvarez-Cuesta E, Bousquet J, Canonica GW, Durham SR, Malling HJ, Valovirta E; EAACI Immunotherapy Task Force: standards for practical allergen-specific immunotherapy. Allergy 2006; 61(suppl 82):1-20.
12. Li MR, Wang XN, Jiang HD, Wang QY, Li YC, Lin J, Jin K, Zhang HL, Li CC: Analysis of adverse reactions induced by subcutaneous immunotherapy against dust mite allergy in 234 cases with allergic rhinitis and asthma. Zhonghua Er Ke Za Zhi 2012; 50: 726-731.
13. Durham SR, Walker SM, Varga EM, Jacobson MR, OBrien F, Noble W, Till SJ, Hamid QA, Nouri-Aria KT: Long-term clinical efficacy of grass-pollen immunotherapy. N Engl J Med 1999; 341: 468-475.
14. Durham SR, Emminger W, Kapp A, de Monchy JG, Rak S, Scadding GK, Wurtzen PA, Andersen JS, Tholstrup B, Riis B, Dahl R: SQ-standardized sublingual grass immunotherapy: confirmation of disease modification 2 years after 3 years of treatment in a randomized trial. J Allergy Clin Immunol 2012; 129: 717-725.
15. Marogna M, Spadolini I, Massolo A, Canonica GW, Passalacqua G: Long-lasting effects of sublingual immunotherapy according to its duration: a 15-year prospective study. J Allergy Clin Immunol 2010; 126: 969-975.
16. Jacobsen L, Niggemann B, Dreborg S, Ferdousi HA, Halken S, Hst A, Koivikko A, Norberg LA, Valovirta E, Wahn U, Möller C; PAT Investigator Group: Specific immunotherapy has long-term preventive effect of seasonal and perennial asthma: 10-year follow-up on the PAT study. Allergy 2007; 62: 943-948.
17. Epstein TG, Liss GM, Murphy-Berendts K, Bernstein DI: Immediate and delayed-onset systemic reactions after subcutaneous immunotherapy injections: ACAAI/AAAAI surveillance study of subcutaneous immunotherapy: year 2. Ann Allergy Asthma Immunol 2011; 107: 426-431.
18. Phillips JF, Lockey RF, Fox RW, Ledford DK, Glaum MC: Systemic reactions to subcutaneous allergen immunotherapy and the response to epinephrine. Allergy Asthma Proc 2011; 32: 288-294.
19. Calderón MA, Simons FE, Malling HJ, Lockey RF, Moingeon P, Demoly P: Sub-lingual allergen immunotherapy: mode of action and its relationship with the safety profile. Allergy 2012; 67: 302-311.
20. Bozek A, Kozlowska R, Jarzab J: The safety of specific immunotherapy for patients allergic to house-dust mites and pollen in relation to the development of neoplasia and autoimmune disease: a long-term, observational case-control study. Int Arch Allergy Immunol 2014; 163: 307-312.
21. Di Lorenzo G, Mansueto P, Pacor ML, Rizzo M, Castello F, Martinelli N, Ditta V, Lo Bianco C, Leto-Barone MS, DAlcamo A, Di Fede G, Rini GB, Ditto AM: Evaluation of serum s-IgE/total IgE ratio in predicting clinical response to allergen-specific immunotherapy. J Allergy Clin Immunol 2009; 123: 1103-1110.
22. Gupta RS, Lau CH, Hamilton RG, Donnell A, Newhall KK: Predicting outcomes of oral food challenges by using the allergen-specific IgE-total IgE ratio. J Allergy Clin Immunol Pract 2014; 2: 300-305.
23. Haselkorn T, Szefler SJ, Simons FE, Zeiger RS, Mink DR, Chipps BE, Borish L, Wong DA; TENOR Study Group: Allergy total serum immunoglobulin E, and airflow in children and adolescents in TENOR. Pediatr Allergy Immunol 2010; 21: 1157-1165.
24. Frew AJ, Powell RJ, Corrigan CJ, Durham SR; UK Immunotherapy Study Group: Efficacy and safety of specific immunotherapy with SQ allergen extract in treatmentresistant seasonal allergic rhinoconjunctivitis. J Allergy Clin Immunol 2006; 117: 319-325.
25. Calderón MA, Cox L, Casale TB, Moingeon P, Demoly P: Multiple-allergen and single-allergen immunotherapy strategies in polysensitized patients: looking at the published evidence. J Allergy Clin Immunol 2012; 129: 929-934.
26. Holt PG, Sly PD: Viral infections and atopy in asthma pathogenesis: new rationales for asthma prevention and treatment. Nat Med 2012; 18: 726-735.
27. Ballardini N, Kull I, Lind T, Hallner E, Almqvist C, Ostblom E, Melén E, Pershagen G, Lilja G, Bergström A, Wickman M: Development and comorbidity of eczema, asthma and rhinitis to age 12: data from the BAMSE birth cohort. Allergy 2012; 67: 537-544.
28. Arshad SH, Karmaus W, Raza A, Kurukulaaratchy RJ, Matthews SM, Holloway JW, Sadeghnejad A, Zhang H, Roberts G, Ewart SL: The effect of parental allergy on childhood allergic diseases depends on the sex of the child. J Allergy Clin Immunol 2012; 130: 427-434.
29. Kita H: Eosinophils: multifunctional and distinctive properties. Int Arch Allergy Immunol 2013; 161(suppl 2):3-9.
30. Nair P: What is an eosinophilic phenotype of asthma? J Allergy Clin Immunol 2013; 132: 81-83.